ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,247 | -24.6% | 45,436 | +33.7% | 0.00% | – |
| Q2 2023 | $82,582 | -62.5% | 33,984 | -11.2% | 0.00% | – |
| Q1 2023 | $220,331 | -86.3% | 38,252 | -78.8% | 0.00% | – |
| Q4 2022 | $1,613,223 | -6.1% | 180,450 | +49.4% | 0.00% | – |
| Q3 2022 | $1,718,000 | +420.6% | 120,782 | +433.6% | 0.00% | – |
| Q2 2022 | $330,000 | -53.5% | 22,636 | -36.3% | 0.00% | – |
| Q1 2022 | $710,000 | -44.6% | 35,538 | -51.5% | 0.00% | – |
| Q4 2021 | $1,281,000 | +1193.9% | 73,258 | +477.7% | 0.00% | – |
| Q3 2021 | $99,000 | +20.7% | 12,681 | +60.2% | 0.00% | – |
| Q2 2021 | $82,000 | -58.2% | 7,914 | -47.3% | 0.00% | – |
| Q1 2021 | $196,000 | +3166.7% | 15,005 | +3227.1% | 0.00% | – |
| Q4 2020 | $6,000 | -78.6% | 451 | -80.7% | 0.00% | – |
| Q3 2020 | $28,000 | – | 2,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |